Nobilis Reo inac
Nobilis Reo inac
Authorised
- Avian reovirus, strain 2408, Inactivated
- Avian reovirus, strain 1733, Inactivated
Product identification
Medicine name:
Nobilis Reo inac
Active substance:
- Avian reovirus, strain 2408, Inactivated
- Avian reovirus, strain 1733, Inactivated
Target species:
-
Chicken
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Avian reovirus, strain 2408, Inactivated7.40log2 enzyme-linked immunosorbent assay unit(s)0.50millilitre(s)
-
Avian reovirus, strain 1733, Inactivated7.40log2 enzyme-linked immunosorbent assay unit(s)0.50millilitre(s)
Pharmaceutical form:
-
Emulsion for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Chicken
-
Egg0day
-
Egg0day
-
Meat and offal0day
-
-
-
Subcutaneous use
-
Chicken
-
Egg0day
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AA04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Paul-Ehrlich-Institut
Authorisation number:
- 461a/87
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 6/02/2024
How useful was this page?: